MwanzoCAMRF • OTCMKTS
add
Camurus AB
Bei iliyotangulia
$ 71.00
Bei za mwaka
$ 50.97 - $ 71.07
Thamani ya kampuni katika soko
38.30B SEK
Wastani wa hisa zilizouzwa
7.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
STO
Habari za soko
The Wall Street Journal
saa 14 zilizopita
Stock Market News, Aug. 8, 2025: Gold Pares Gains; Dow Rises
0.47%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (SEK) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 675.50M | 51.84% |
Matumizi ya uendeshaji wa biashara | 342.31M | 3.59% |
Mapato halisi | 244.79M | 229.91% |
Kiwango cha faida halisi | 36.24 | 117.27% |
Mapato kwa kila hisa | 4.08 | 226.40% |
EBITDA | 298.33M | 245.49% |
Asilimia ya kodi ya mapato | 20.27% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (SEK) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 3.35B | 30.40% |
Jumla ya mali | 4.42B | 28.90% |
Jumla ya dhima | 553.52M | 9.89% |
Jumla ya hisa | 3.87B | — |
hisa zilizosalia | 59.42M | — |
Uwiano wa bei na thamani | 1.09 | — |
Faida inayotokana na mali | 17.40% | — |
Faida inayotokana mtaji | 19.29% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (SEK) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 244.79M | 229.91% |
Pesa kutokana na shughuli | 375.78M | 280.55% |
Pesa kutokana na uwekezaji | -27.41M | -1,325.33% |
Pesa kutokana na ufadhili | 121.94M | -37.94% |
Mabadiliko halisi ya pesa taslimu | 469.37M | 60.07% |
Mtiririko huru wa pesa | 230.39M | 238.08% |
Kuhusu
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1991
Tovuti
Wafanyakazi
267
